We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Alendronate induced subacute cutaneous lupus erythematosus successfully treated with intravenous immunoglobulin.
- Authors
Uzuncakmak, Tugba Kevser; Bayazit, Samet; Askin, Ozge; Engin, Burhan; Ugurlu, Serdal; Sar, Mehmet; Serdaroglu, Server
- Abstract
The subacute cutaneous lupus erythematosus (SCLE) is a distinct subtype of lupus erythematosus (LE) representing specific clinical and serological features. Almost 20%‐30% of the cases with SCLE are predicted to associated with medications. Thiazide diuretics, terbinafine, antiepileptic, and proton pump inhibitors are the best‐known drugs to induce drug‐related SCLE. Herein we want to present a 65‐year‐old female with alendronate induced SCLE, resistant to classical therapies, and respond well to intravenous immunoglobulin (IVIG), suggesting that IVIG could be an alternative treatment in patients resistant to classical treatment protocols.
- Subjects
LUPUS erythematosus; ALENDRONATE; PROTON pump inhibitors; TERBINAFINE; MEDICAL protocols
- Publication
Dermatologic Therapy, 2020, Vol 33, Issue 6, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.14477